{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T07:51:34Z","timestamp":1793260294800,"version":"4.5.0"},"reference-count":17,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T00:00:00Z","timestamp":1779753600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Invasive pulmonary aspergillosis (IPA) is more common among immunocompromised patients. Timely diagnosis is crucial but is challenging because current diagnostic approaches are often limited by low sensitivity, prolonged turnaround times, and technical complexity. Here, we developed a fully automated, real-time PCR\u2013based, sample-to-answer molecular diagnostic platform for the simultaneous identification of four major\n                      <jats:italic>Aspergillus<\/jats:italic>\n                      species (\n                      <jats:italic>A. fumigatus, A. flavus, A. niger<\/jats:italic>\n                      , and\n                      <jats:italic>A. terreus<\/jats:italic>\n                      ).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and methods<\/jats:title>\n                    <jats:p>\n                      The sample-to-answer workflow was optimized using artificial bronchoalveolar lavage (BAL) samples spiked with\n                      <jats:italic>Aspergillus<\/jats:italic>\n                      species. The platform\u2019s performance was evaluated through two primary validation steps: analytical consistency with MALDI-TOF using 21 patient-derived culture isolates, and clinical feasibility validation using 22 clinical BAL specimens from patients categorized as proven (\n                      <jats:italic>n<\/jats:italic>\n                      = 11) or probable (\n                      <jats:italic>n<\/jats:italic>\n                      = 11) IPA.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The assay demonstrated 95.2% (20\/21) overall agreement with MALDI-TOF for culture isolates, achieving 93.3% positive agreement and 100% negative agreement. In the feasibility validation using 22 patient BAL samples including 11 proven and 11 probable IPA cases, the platform detected 10 out of 11 proven IPA samples (90.9%) with 100% species-level consistency with MALDI-TOF results. Notably, this assay could add mycological evidence in 3 of 11 culture-negative probable IPA cases.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      This fully automated, sample-to-answer platform enables rapid and accurate species-level identification of\n                      <jats:italic>Aspergillus<\/jats:italic>\n                      in suspicious IPA. We highlight that this assay offers a powerful molecular tool to overcome the limitations of conventional diagnostic methods in clinical settings.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmicb.2026.1828196","type":"journal-article","created":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T06:02:27Z","timestamp":1779775347000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["A fully integrated sample-to-answer molecular diagnostic platform for rapid identification of four major Aspergillus species"],"prefix":"10.3389","volume":"17","author":[{"given":"Eun Hae","family":"Oh","sequence":"first","affiliation":[{"name":"iGENETECH R&D Center, iGENETECH Inc.","place":["Yongin, Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinseok","family":"Kang","sequence":"additional","affiliation":[{"name":"iGENETECH R&D Center, iGENETECH Inc.","place":["Yongin, Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dasol","family":"Jin","sequence":"additional","affiliation":[{"name":"iGENETECH R&D Center, iGENETECH Inc.","place":["Yongin, Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaehwa","family":"Yoo","sequence":"additional","affiliation":[{"name":"iGENETECH R&D Center, iGENETECH Inc.","place":["Yongin, Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jihoon","family":"Park","sequence":"additional","affiliation":[{"name":"iGENETECH R&D Center, iGENETECH Inc.","place":["Yongin, Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun Jeong","family":"Won","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Asan Medical Center, University of Ulsan College of Medicine","place":["Seoul, Republic of Korea"]},{"name":"Department of Molecular Genetics and Microbiology, Duke University Medical Center","place":["Durham, NC, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1128\/CMR.00091-13","article-title":"Molecular and nonmolecular diagnostic methods for invasive fungal infections.","volume":"27","author":"Arvanitis","year":"2014","journal-title":"Clin. Microbiol. Rev."},{"key":"B2","doi-asserted-by":"publisher","first-page":"F1000 Faculty Rev-157","DOI":"10.12688\/f1000research.10216.1","article-title":"Challenges in microbiological diagnosis of invasive Aspergillus infections.","volume":"6","author":"Bretagne","year":"2017","journal-title":"F1000Res."},{"key":"B3","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1128\/CMR.00072-12","article-title":"Matrix-assisted laser desorption ionization-time of flight mass spectrometry: A fundamental shift in the routine practice of clinical microbiology.","volume":"26","author":"Clark","year":"2013","journal-title":"Clin. Microbiol. Rev."},{"key":"B4","doi-asserted-by":"publisher","first-page":"CD009551","DOI":"10.1002\/14651858.cd009551.pub4","article-title":"Polymerase chain reaction blood tests for the diagnosis of invasive aspergillosis in immunocompromised people.","volume":"9","author":"Cruciani","year":"2019","journal-title":"Cochrane Database Syst. Rev."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1093\/cid\/ciz1008","article-title":"Revision and update of the consensus definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium.","volume":"71","author":"Donnelly","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"B6","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s40121-017-0154-1","article-title":"A review of diagnostic methods for invasive fungal diseases: Challenges and perspectives.","volume":"6","author":"Falci","year":"2017","journal-title":"Infect. Dis. Ther."},{"key":"B7","doi-asserted-by":"publisher","first-page":"e0327620","DOI":"10.1128\/JCM.03276-20","article-title":"Challenges with utilizing the 1,3-beta-D-glucan and galactomannan assays to diagnose invasive mold infections in immunocompromised children.","volume":"59","author":"Hsu","year":"2021","journal-title":"J. Clin. Microbiol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"e13544","DOI":"10.1111\/ctr.13544","article-title":"Invasive aspergillosis in solid-organ transplant recipients: Guidelines from the American Society of Transplantation infectious diseases community of practice.","volume":"33","author":"Husain","year":"2019","journal-title":"Clin. Transplant."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1080\/14737159.2023.2267977","article-title":"An update on current and novel molecular diagnostics for the diagnosis of invasive fungal infections.","volume":"23","author":"Jenks","year":"2023","journal-title":"Expert Rev. Mol. Diagn."},{"key":"B10","doi-asserted-by":"publisher","first-page":"e0229561","DOI":"10.1371\/journal.pone.0229561","article-title":"Development of multiplex real-time PCR for rapid identification and quantitative analysis of Aspergillus species.","volume":"15","author":"Kim","year":"2020","journal-title":"PLoS One"},{"key":"B11","doi-asserted-by":"publisher","first-page":"e146136","DOI":"10.5812\/archcid-146136","article-title":"Change in global incidence and mortality of invasive fungal infection.","volume":"19","author":"Mardani","year":"2024","journal-title":"Arch. Clin. Infect. Dis."},{"key":"B12","doi-asserted-by":"publisher","first-page":"e14049","DOI":"10.1111\/tid.14049","article-title":"Invasive aspergillosis in liver transplant recipients.","volume":"25","author":"Melenotte","year":"2023","journal-title":"Transpl. Infect. Dis."},{"key":"B13","doi-asserted-by":"publisher","first-page":"103915","DOI":"10.1016\/j.resmic.2021.103915","article-title":"Fungal infections diagnosis \u2013 Past, present and future.","volume":"173","author":"Mendon\u00e7a","year":"2022","journal-title":"Res. Microbiol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/cid\/ciw326","article-title":"Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the Infectious Diseases Society of America.","volume":"63","author":"Patterson","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"B15","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/j.cmi.2025.10.017","article-title":"Laboratory innovations to diagnose invasive mould infections\u2014what is relevant, what is not?","volume":"32","author":"Vanbiervliet","year":"2025","journal-title":"Clin. Microbiol. Infect."},{"key":"B16","doi-asserted-by":"publisher","first-page":"2832","DOI":"10.1128\/JCM.00905-15","article-title":"Clinical performance of Aspergillus PCR for testing serum and plasma: A study by the European Aspergillus PCR Initiative.","volume":"53","author":"White","year":"","journal-title":"J. Clin. Microbiol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1093\/cid\/civ507","article-title":"Aspergillus polymerase chain reaction: Systematic review of evidence for clinical use in comparison with antigen testing.","volume":"61","author":"White","year":"","journal-title":"Clin. Infect. Dis."}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2026.1828196\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T06:02:28Z","timestamp":1779775348000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2026.1828196\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,26]]},"references-count":17,"alternative-id":["10.3389\/fmicb.2026.1828196"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2026.1828196","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,26]]},"article-number":"1828196"}}